Jeffrey Bogart

5PUBLICATIONS
38CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 20, 2023
The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLC.

Joanne B Weidhaas, Chen Hu, Ritsuko Komaki

|May 25, 2023
Effect of Lymphopenia on Tumor Response and Clinical Outcomes Following Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer.

Jared Deck, Marissa Hartley, Mohammad Akhter

|Jan 09, 2023
High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538.

Jeffrey Bogart, Xiaofei Wang, Gregory Masters

|Oct 21, 2022
Positron Emission Tomography-Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance).

Ann S LaCasce, Travis Dockter, Amy S Ruppert

Pageof 1